产品: DNAJA1 抗体
货号: DF8940
描述: Rabbit polyclonal antibody to DNAJA1
应用: WB IHC IF/ICC
文献验证: IHC
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog
蛋白号: P31689
RRID: AB_2842136

浏览相似产品>>

   规格 价格 库存
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
DNAJA1 Antibody detects endogenous levels of total DNAJA1.
RRID:
AB_2842136
引用格式: Affinity Biosciences Cat# DF8940, RRID:AB_2842136.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

DJ 2; DJ2; DjA1; DnaJ (Hsp40) homolog, subfamily A, member 1; DnaJ homolog subfamily A member 1; DnaJ protein homolog 2; DNAJ2; Dnaja1; DNJA1_HUMAN; hDJ 2; HDJ-2; HDJ2; Heat shock 40 kDa protein 4; heat shock protein DNAJ like 2; Heat shock protein J2; HSDJ; HSJ-2; HSJ2; HSPF4; Human DnaJ protein 2; NEDD7; Neural precursor cell expressed developmentally down regulated 7; OTTHUMP00000021193;

抗原和靶标

免疫原:

A synthesized peptide derived from human DNAJA1, corresponding to a region within C-terminal amino acids.

基因/基因ID:

研究领域

· Genetic Information Processing > Folding, sorting and degradation > Protein processing in endoplasmic reticulum.   (View pathway)

文献引用

1). Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study. Cellular oncology (Dordrecht, Netherlands), 2024 (PubMed: 39714755) [IF=4.9]

Application: IHC    Species: human    Sample:

Fig. 5 IHC staining and scoring for classifying patients in Xinhua cohort based on RCC-TSC. A The flowchart of our study. Our clinical study was mainly composed of three analytic processes, including IHC staining for the tumor tissue of the 370 patients with kidney neoplasm, molecular diagnosis based on the RCC-TSC, and statistical validation. The inclusion and exclusion criteria were also shown in detail. Firstly, 370 patients with kidney neoplasm and received curative surgery from 2016–2018 were included. Secondly, due to the incompleteness of the IHC staining information (DNAJA1, DNAJB4, LAG3, Mki67), one patient was excluded. Thirdly, when performing Chi-square tests and Kaplan-Meier survival analysis, 71 (lacking OS censor and PFS censor) or 75 patients (lacking OS and PFS) were correspondingly excluded. Finally, when conducting the multivariate proportional hazards Cox regression analysis, 10 patients whose histopathological classifications were not KICH, KIRC, or KIRP were excluded. B The boxplots showed the relative expression in transcriptional level for the four markers we used for IHC staining and classification. MKi67 and LAG3, DNAJA1 and DNAJB3 respectively expressed highest in HIRC and LIRC. C The heatmap illustrated the information of the 370 patients in our retrospective cohort. D IHC slides demonstrated the differential staining results of DNAJA1, DNAJB4, LAG3, Mki67 in three RCC-TSC subtypes. Specifically, DNAJA1 and DNAJB4 both had relatively high, medium, and low staining score in LIRC, MIRC, and HIRC. While LAG3, Mki67 both had relatively high, medium, and low staining score in HIRC, MIRC, and LIRC. IHC, immunohistochemical; RCC-TSC, renal cell carcinoma-Treg states-related prognostic classification; OS, overall survival; PFS, progression-free survival; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; LIRC, low immune infiltration RCC; MIRC, medium immune infiltration RCC; HIRC, high immune infiltration RCC

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.